Comparison of baseline clinical characteristics among people with type 2 diabetes on second-line therapy previously added with dapagliflozin or another oral glucose-lowering drug: AGORA study Vicente Pallarés-Carratalá; Antonio Ruiz-García; Adalberto Serrano-Cumplido; Antonio Segura Fragoso; Verónica Fernández-Pascual; Beatriz Sánchez-Sánchez; María Inmaculada Cervera-Pérez; Francisco Javier Alonso-Moreno; Ezequiel Arranz-Martínez; Alfonso Barquilla-García; Daniel Rey-Aldana; José Polo García; Sergio Cinza-Sanjurjo;

Increasing muscular strength to improve cardiometabolic risk factors Patricio Lopez-Jaramillo; Jose P. Lopez-Lopez; Maria Camila Tole; Daniel D. Cohen;

Challenges and perspectives of the double burden of malnutrition in Latin America Ángela Hernández-Ruiz; Casandra Madrigal; María José Soto-Méndez; Ángel Gil;